BPC-157: Preclinical Research Overview

What is BPC-157?

BPC-157 (short for Body Protection Compound-157) is a peptide — a short chain of amino acids, the same building blocks that make up proteins. This one is made of 15 of those building blocks (its sequence is GEPPPGKPADDAGLV), which is why scientists call it a pentadecapeptide ("penta-deca" just means fifteen). It is a lab-made copy of a small piece of a natural protein found in stomach juice. In animal studies, researchers have looked at how it relates to tissue repair (the body fixing damage), angiogenesis (the growing of new blood vessels), and protecting the gut. Velox supplies it strictly as a research chemical for in vitro use — that means test-tube and lab work only, never for people or animals.

One thing that makes BPC-157 stand out in research is that it is tough. It stays in one piece when mixed into water or exposed to stomach-like conditions in the lab, while many other peptides fall apart. That stability is a big reason scientists use it so often in studies of how cells heal and move.

Mechanisms Studied in Preclinical Research

In lab and animal studies, the same few biological pathways (the chains of chemical signals cells use to talk to each other) keep coming up with BPC-157. Here is a plain summary of what researchers have observed — these are research findings only, not proof it treats anything.

Angiogenesis & the VEGFR2–eNOS–NO pathway

Studies in cells and in rodents have looked at BPC-157 and angiogenesis — the growing of new blood vessels. They noted links to a signal called VEGFR2 (think of it as a "docking point" on a cell that tells it to start building new vessels) and to nitric oxide, a molecule that helps blood vessels relax and form. These were seen in endothelial cells, the cells that line the inside of blood vessels.[1]

Tendon & ligament fibroblasts

Lab work on tendon fibroblasts (the cells that build and repair tendons) has reported changes in how those cells grow, survive and move, plus changes in their growth-hormone receptors. These are common things scientists measure when studying how tissue repairs itself.[2]

Gastrointestinal mucosal integrity

Because BPC-157 comes from a piece of a stomach protein, a lot of the early research looked at the gut lining (the protective layer inside the digestive system) and the gut-brain axis (the two-way connection between the gut and the brain), using animal injury models.[3]

BPC-157 is often studied alongside TB-500 in tissue-repair models, where the two are thought to work in different but complementary ways — one linked to new blood vessels, the other to how cells move. For a side-by-side breakdown, see BPC-157 vs TB-500.

Key Research Literature

BPC-157 has an extensive preclinical literature, much of it from the research groups of Sikiric and Seiwerth and collaborators. Selected representative work:

Summaries above are derived from publicly available peer-reviewed literature and describe research observations only. They are not claims of efficacy or safety in humans.

Handling in the Laboratory

Velox BPC-157 comes as a lyophilised (freeze-dried) powder. Before use in the lab it is reconstituted — mixed back into a liquid — using bacteriostatic water (sterile water with a preservative that stops bacteria growing). Our reconstitution calculator helps work out the concentration.

• Lyophilised storage: −20°C, dry and dark.
• Reconstituted storage: 2–8°C; avoid freeze–thaw cycles.
• Verification: every batch is third-party HPLC-tested; batch documentation available on request.

References

1. Research on BPC-157 and VEGFR2/eNOS-NO angiogenic signalling — see PubMed.
2. Chang C-H, Tsai W-C, et al., J Appl Physiol, 2011 — tendon fibroblast outgrowth, survival and migration. PubMed.
3. Sikiric P, Seiwerth S, et al. — reviews of BPC-157 in gastrointestinal and gut-brain-axis research models. PubMed.

Frequently Asked Questions